Repligen | Actif À Court Terme



Current Assets Changement Date
Agilent USD 4.11B 148M 2025-01
Align Technology USD 2.49B 104.95M 2024-12
Bio Techne USD 634.64M 13.93M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Bruker USD 2.06B 133.1M 2024-12
Charles River Laboratories USD 1.4B 91.65M 2024-12
Danaher USD 9.5B 563M 2024-12
Dentsply International USD 1.75B 175M 2024-12
Exact Sciences USD 1.57B 38.31M 2024-12
General Electric USD 37.64B 1.01B 2024-12
Henry Schein USD 3.98B 164M 2024-12
Illumina USD 2.75B 373M 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
Mettler Toledo International USD 1.19B 4.33M 2024-12
Myriad Genetics USD 298M 4.8M 2024-12
Patterson Companies USD 1.84B 4.38M 2025-01
Pfizer USD 50.36B 7.14B 2024-12
Repligen USD 1.07B 65.53M 2024-12
Revvity USD 2.35B 98.8M 2024-12
Standard Biotools USD 375.88M 77.73M 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12
Waters USD 1.67B 21.39M 2024-12
West Pharmaceutical Services USD 1.54B 12.5M 2024-12



Repligen Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.